Vora Amit N, Rao Sunil V
Duke University Medical Center, Duke Clinical Research Institute, Durham, NC, USA.
J Thorac Dis. 2018 Nov;10(Suppl 30):S3595-S3598. doi: 10.21037/jtd.2018.09.48.
Transcatheter aortic valve implantation is an important therapeutic option for patients with symptomatic, severe aortic stenosis at increased risk for open surgical aortic valve replacement. Although a number of alternative vascular access sites have been developed, transfemoral access is overwhelmingly the dominant access strategy for this procedure. Access was achieved in the initial clinical experience primarily via surgical cutdown, but more recently, there has been increasing use of a fully percutaneous approach. This is likely driven by improvements in technology, more experience with large bore vascular closure devices (VCDs), and pressures to reduce hospital length of stay. This review will describe temporal trends of percutaneous versus surgical transfemoral access, identify the advantages and disadvantages of each approach, and describe the best practices for achieving safe transfemoral percutaneous access.
经导管主动脉瓣植入术是有症状的严重主动脉瓣狭窄患者的重要治疗选择,这些患者接受开放性外科主动脉瓣置换术的风险增加。尽管已经开发了许多替代血管入路部位,但经股动脉入路在该手术中绝对是主要的入路策略。在最初的临床经验中,主要通过手术切开实现入路,但最近,越来越多地使用完全经皮入路。这可能是由于技术的改进、对大口径血管闭合装置(VCD)有了更多经验以及缩短住院时间的压力所驱动。本综述将描述经皮与外科经股动脉入路的时间趋势,确定每种方法的优缺点,并描述实现安全经股动脉经皮入路的最佳实践。